End-to-End Cold Chain for Clinical Trials

Understanding Cold Chain Logistics in Clinical Trials

Cold chain logistics form the backbone of clinical trials involving temperature-sensitive materials. These shipments often contain biological specimens, investigational medicinal products (IMPs), vaccines, or high-value reagents. Any deviation from the specified temperature range can lead to sample degradation, data loss, or even trial failure.

As clinical trials expand across borders, cold chain logistics must address complex international regulations, long transit durations, and climate variability. Trials often span multiple countries and require coordination across customs agencies, depots, and collection sites, which makes a consistent, validated logistics infrastructure non-negotiable.

Start with Comprehensive Planning

Successful cold chain logistics start with detailed protocol-based planning. This includes mapping out study timelines, site locations, sample collection windows, and the characteristics of each shipment type. You must define precise storage conditions, delivery timeframes, and contingency procedures.

Collaborate early with stakeholders, including clinical operations, CROs, and logistics vendors. Outline each step from kit assembly to patient delivery, and build a shipping matrix that allows time to validate packaging under simulated transport conditions.

Choose the Right Temperature Range

Temperature ranges for clinical trial materials vary based on the product's stability profile:

• Cryogenic: -80 degrees C or below for cell and gene therapies

• Frozen: -20 degrees C for vaccine components and DNA samples

• Refrigerated: 2 to 8 degrees C for biologics and serology kits

• Controlled room temperature: 15 to 25 degrees C for oral solids or diagnostic instruments

Review each material's stability data, duration of transport, and ambient conditions. Include route-specific challenges like seasonal heatwaves or customs delays, and choose temperature lanes with buffer ranges that minimize excursions.

Use Validated Packaging Solutions

Thermal packaging must be qualified through thermal validation studies that simulate transit durations under extreme conditions and confirm the package's ability to hold internal temperature. Dry ice shippers, vacuum-insulated panels, and phase change materials are standard options.

Select single-use or reusable containers depending on cost, location, and shipment frequency. Pair packaging with internal temperature data loggers for added verification, and confirm compliance with Good Distribution Practice and IATA Dangerous Goods Regulations.

Cold Chain Validation and Testing

Validation is not a one-time check. It is the documented proof that a specific packaging configuration holds its target temperature range for the full expected transit time, including realistic delays. A validation protocol typically tests worst-case summer and winter conditions, then records the internal temperature curve against the required range.

Container closure integrity testing (CCIT) confirms that a vial, cartridge, or container maintains a sealed barrier against contamination throughout the shipment. For biologics and sterile products, CCIT results are often requested directly by auditors alongside temperature validation data.

Sample repositories and biobanks carry an added validation burden, since a single container may be opened, resealed, and reshipped multiple times across a study's life. Repository-bound shipments should use packaging validated for repeated freeze-thaw cycles, not just a single transit leg.

Ensure Compliance with Regulations

Clinical trial shipments fall under multiple regulatory frameworks: IATA for air transport, DOT for ground shipping, and EMA/FDA for pharmaceutical standards.

For infectious substances, you may need to classify them under UN 3373 (Biological Substance Category B) or UN 2814 (Infectious Substances Affecting Humans Category A).

Labeling must reflect shipping classification, contents, sender, consignee, and required handling. Missing or incorrect labels may result in customs seizure, so confirm import licenses, toxic substance certifications, and health authority approvals are in place before dispatch.

Account for Last-Mile Logistics

The last mile often involves delivery to clinical sites, pharmacies, or directly to patients, and it is a critical touchpoint in both the patient experience and the clinical protocol. This phase demands precision delivery, often within hours and sometimes with special handling instructions.

White glove delivery services include in-room placement, setup support, and secure chain-of-custody handoff. For decentralized clinical trials, residential delivery must follow privacy, temperature integrity, and contactless protocols.

For a complete overview of Mercury's clinical trial shipping capabilities, visit our clinical trial logistics page.

Use Real-Time Tracking and Monitoring

Real-time data visibility improves decision-making. Equip shipments with GPS-enabled trackers and Bluetooth temperature loggers that provide continuous updates on shipment location, internal temperature, and security status.

Advanced dashboards provide alerts for temperature excursions, tampering, or unexpected delays. These records serve as audit trails for inspections and support compliance with ICH E6(R2) Good Clinical Practice.

Prepare for Customs and Delays

Cross-border shipping requires a deep understanding of country-specific import laws. Many biological materials and IMPs require import permits, toxic substance declarations, or biosafety approvals.

Partner with logistics providers who specialize in clinical trial importation, and maintain a customs documentation checklist that includes pro forma invoices, waybills, certificates of analysis, and permits.

Document Everything

Traceability is essential in clinical trials. Maintain a master file for each shipment type containing material safety data sheets, certificates of compliance, temperature validation reports, and delivery confirmations.

Use electronic systems to digitize and archive shipment records. These documents support regulatory audits, sponsor reviews, and quality investigations.

Train All Stakeholders

Cold chain logistics involve collaboration across packaging teams, couriers, and clinical site staff. Provide role-specific training so everyone understands their responsibilities, including packaging assembly, chain-of-custody procedures, temperature breach handling, and documentation requirements.

Conduct annual refreshers and simulate mock shipments to assess readiness before a real study depends on it.

Adapt to Decentralized Trial Models

Decentralized clinical trials eliminate traditional trial sites, requiring materials to be shipped to and from patient homes. This introduces variability in location, delivery timing, and recipient availability.

Plan shipments using patient calendars and confirm delivery readiness with recipients. White glove delivery, remote temperature monitoring, and two-way communication channels are essential to maintain control and compliance in decentralized trials.

How Mercury Supports Clinical Trial Logistics

Mercury provides end-to-end cold chain logistics tailored for clinical trials, supporting global pharmaceutical, biotech, diagnostics, and life science companies with reliable, compliant shipping services.

Our team helps design your logistics strategy, select validated packaging, and prepare the required paperwork, from IATA compliance to import licensing. We supply and precondition validated packaging across all temperature lanes, with around-the-clock monitoring, GPS tracking, and live alerts for temperature, location, and milestones.

We manage international documentation, proactively communicate with customs, and serve as your logistics control tower, managing site coordination, time-sensitive pickups, and direct-to-patient deliveries so nothing depends on guesswork.

Contact Mercury to build a validated, compliant cold chain plan for your next clinical trial shipment.